Life Sciences 2021 Year in Review

This webinar has ended.


From wide-ranging decisions touching on major issues in life sciences to a high-profile dispute concerning the country’s most popular COVID-19 vaccine, patent litigation in the life sciences industry continued apace in 2021.

On Wednesday, February 16, please join Fish attorneys Anita Meiklejohn and Susan Morrison for an overview of some of the most important IP developments in the life sciences industry in 2021. Our hosts will discuss:

  • Amgen v. Sanofi
  • Juno Therapeutics v. Kite Pharma
  • Biogen v. Mylan
  • Indivior v. Dr Reddy’s
  • Allele v. Pfizer
  • GSK v. Teva
  • Jennewein v. ITC
  • Teva v. Corcept

Download a Copy of the Webinar Slides